Reference 2017-366

REF:            2017-366

Subject:        Wet Age Related Macular

          

 

Request:

Within your trust how many patients have been treated, in the past 6 months January to June, 2017 by diagnosed eye condition. Of these patients how many are new to treatment [they have not previously received an injection /implant]?

 

Total Patients New Patients Lucentis (ranibizumab) Patients Lucentis (ranibizumab) NEW Patients Eylea (aflibercept) Patients Eylea (aflibercept) NEW Patients

 

Total
Wet Age Related Macular Degeneration (wAMD)            
Other conditions (DMO, RVO or mCNV)            

 

 

Response:

Please find attached the information we can supply for the FOI.  Unfortunately we are unable to provide data broken down by new and existing patients.  We are also unable to provide a breakdown by indication so the figures below indicate total patients for all indications in ophthalmology.

 

Total Patients New Patients Lucentis (ranibizumab) Patients Lucentis (ranibizumab) NEW Patients Eylea (aflibercept) Patients Eylea (aflibercept) NEW Patients

 

Total 896 513 383